MOSCOW – Russia’s Ministry of Health gave regulatory approval for the world’s first COVID-19 vaccine, developed through the Gamaleya Institute in Moscow, after less than two months of human testing, President Vladimir Putin said Tuesday.
This resolution paves the way for mass inoculation even as the final stages of clinical trials continue to verify protection and efficacy.
The speed with which Russia is deploying its vaccine hides its determination to win the global race for an effective product, however, has raised considerations that it can put national prestige ahead of science and safety. (Reporting through Maxim Rodionov and Vladimir Soldatkin; written through Alexander Marrow / Gabrielle Tétrault-Farber; edited through Kevin Liffey)
Sign up for news from the National Post, a department of Postmedia Network Inc.
An error has occurred, provide a valid email address.
A welcome email is on the way. If you don’t see it, check your unwanted folder.
The next factor in the newsletter will soon be in your inbox.
We found a challenge when you signed up. Please check again
Postmedia is committed to remaining a civilized discussion forum and encouraging all readers to express their views in percentage on our articles. Comments can take up to an hour to moderate before appearing on the site. We ask that you keep your comments applicable and respectful. We’ve enabled email notifications. You will now receive an email if you get a reaction to your comment, if there is an update to a comment thread that follows, or if a user follows it. Check out our network regulations for more data and main points on how to adjust your email settings.
365 Bloor Street East, Toronto, Ontario, M4W 3L4
© 2020 National Post, a department of Postmedia Network Inc. All rights reserved. Unauthorized dissemination, transmission or dissemination is strictly prohibited.
This uses cookies to personalize your content (including ads) and allows us to analyze our traffic. Learn more about cookies here. By using our site, you agree to our terms of use and our privacy policy.